Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Vimizim® (elosulfase alfa)
Locations
79
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's Hospital of Los Angeles
Los Angeles, California, United States
University of Southern California
Los Angeles, California, United States
Children's Hospital of Orange County
Orange, California, United States
A.I. Dupont Hospital for Children
Wilmington, Delaware, United States
Start Date
September 1, 2014
Primary Completion Date
February 21, 2024
Completion Date
February 21, 2024
Last Updated
March 5, 2024
NCT03632213
NCT01966029
NCT01609062
NCT01242111
NCT00787995
Lead Sponsor
BioMarin Pharmaceutical
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions